October 31st 2024
The study compared AB-Biotics and Kaneka Probiotics’ probiotic formulation of Bifidobacterium longum KABP®-042 and Pediococcus pentosaceus KABP®-041 to Lactobacillus reuteri DSM17938 (LR) from Biogaia.
IFF Health is hosting a virtual probiotics summit for co-manufacturers in the microbiome space
June 8th 2021Howaru Probiotics, part of IFF Health, will be hosting an event called Empower CM that is tailored to equip co-manufacturers with insights and solutions that will help them innovate and lead the future of microbiome health and wellness.
Bio-Cat Microbials announced GRAS status of its Opti-Biome probiotic strain
April 20th 2021Bio-Cat Microbials LLC has received a “Letter of No Objection” from the U.S. Food and Drug Administration (FDA) regarding the company’s GRAS (generally recognized as safe) notice for its Opti-Biome Bacillus subtilis MB40 probiotic.
Pendulum Therapeutics secures funding to help meet consumer demand
April 12th 2021The new venture capital funding will be used to increase the manufacturing and sales of Pendulum Glucose Control, ramp up the manufacturing of pipeline products to address the management of other chronic diseases, and conduct additional research, including clinical trials.
CRN launches its retailer and consumer education campaign on probiotics
April 2nd 2021The Council for Responsible Nutrition launched "Probiotics: What’s Inside is Alive," a campaign that educates retail buyers and customers about probiotics, to help retail buyers better curate their offerings, improves retailer handling including storage, and informs customers about their benefits.